with established and treated epilepsy before age of 65 while presented uncontrolled epilepsies in their elderly life were not included. Epilepsy is defined as at least two unprovoked seizures occurring more than 24 h apart. Those with a single unprovoked seizure or acute symptomatic seizures were excluded [3] . The diagnosis was clinical and supplemented by electroencephalography (EEG). Participants were divided into the early-onset group (those with a first seizure before the age of 65 years but had never been diagnosed or treated) and the late-onset group (those with first seizure after the age of 65 years).
Clinical data collection
Data collected included gender, age at admission, age at the seizure onset and disease duration. Results of EEG and MRI/CT scans were reviewed and recorded. Local or generalized slow waves in the EEG recording were considered as non-specific abnormalities, while local or generalized paroxysms sharp waves, spike waves, sharp and slow waves, spike and slow waves were teemed as epileptiform discharges. Comorbidity, defined as cooccurrence of two or more separate medical conditions in the same person, was recorded. Information of anti-epileptic drugs (AEDs) and concomitant drugs with epileptogenic potentials a previously suggested [4] were also collected.
Epileptic seizures were classified as focal or generalized seizures [5] . Status epilepticus (SE) was defined as any clinical or electrophysiological epileptic activity that lasted for more than 5 min or recurrent epileptic activity without recovery of the consciousness over 5 min [6] . The etiology of epilepsy was classified as genetic, structural, metabolic, immune, infectious or unknown [7] . The potential causes were further classified into different categories as suggested in international guidelines [3, 5] .
Follow-up
All enrolled people were followed up as outpatient visit or by telephone interview for two years. Seizure-free or more than 50% reduction in seizure frequency was considered as AEDs effective, while less than 50% reduction or increase in seizure was defined as AEDs non-effective at follow-up.
The study was approved by the Ethics Committees of West China Hospital, Sichuan University. All participants provided informed consent.
Statistical analysis
Continuous variables were reported as the median (range) or mean AE SD while categorical variables were described in terms of frequency. Two-tailed t test was used for continuous variables and chi-square test was applied for categorical variables. Fisher's exact test was used for the relatively small sample size. The correlates of epilepsy prognosis were determined using logistic regression models and optimum subsets regression. Two-sided p-value <0.05 was considered to be statistically significant. Statistical analyses were performed using SPSS 20.0 software.
Results

Demographic data
There were 486 admissions for seizures during the recruitment period. Eighty-nine people had acute symptomatic seizures and 36 only had a single unprovoked seizure at initial presentation and were excluded. Three further patients who were initially excluded but had later recurrence were then included (see Fig. 1 ). Twenty-one refused consent, thus a total of 340 people were included. Among these, 214 (63%) were male and the median age was 73.5 years (range 65-97 years) (see Table 1 ). Forty-five (13.2%) patients with seizure onset before age of 65 years were classified into early-onset group, and 295 (86.8%) were included into lateonset group. One participant in the early-onset group had seizures since childhood and three had seizures since early adulthood but had not been diagnosed as epilepsy prior to their referral to the hospital. Twenty-six (7.6%) were lost follow-up and 16 (4.7%) died during the follow-up period (cardiac failure, pulmonary infections, cancer, stroke or other causes). 
EEG and MRI/CT results
EEG was recorded on 171 (50.3%) people. Epileptiform discharges with focal sharp waves or spike waves onset were seen in 16.4% (see Table 1 ). Three hundred and twelve (91.8%) had neuroimaging evaluation (234 had MRI and 78 only had CT scan) and structural abnormalities were detected in 92.9%.
Epilepsy characteristics
Focal seizure was the most common type of seizure in both groups, accounting for approximately 80% of all cases (see Table 1 ). Compared with the early-onset group, significantly more people in late-onset group had experienced SE at least once (64.4% vs. 46.7%, p = 0.022). SE was the first presentation of epilepsy in 135 (45.8%) with no significant difference seen between the two groups.
Etiology of epilepsy and potential causes
Fifty-seven percent had an etiological diagnosis (see Table 1 ), 91.8% of which were made on MRI/CT images and 8.2% on clinical manifestations. The etiological diagnosis was more prevalent in the late-onset group. Significantly more in late-onset group were found having epilepsies secondary to ischemic stroke than that in early-onset group (24.4% vs. 11.1%, p = 0.047).
AEDs application and seizure control
Eighty percent of the participants were treated with AEDs (see Table 1 and Supplementary Table 1) . Compared with the earlyonset group, more people with late-onset epilepsy were on monotherapy (40% vs. 20%, p = 0.010).
Follow-up was complete in 298 people and 42 (12.4%, 42/340) were lost to follow-up. Two-hundred and forty (70.6%, 240/340) had significant reduction of seizure frequency and were categorized into the AEDs effective group, 58 (17.1%, 58/340 in AEDs non-effective group (see Table 2 ). One hundred and eighty-four (54.1%, 184/340) were seizure-free and 56 (16.4%, 56/340) had more than 50% seizure reduction. Compared with the early-onset group, more of those with late-onset epilepsy achieved satisfactory seizure outcome (82.7% vs. 66.7%, p = 0.011). 83.5% of those who received at least one AED reached favorable seizure control, which was significantly higher than that of people without AEDs (83.5% vs. 68.7%, p = 0.008). The number of AEDs taken had no significant impact on seizure outcome. 
Comorbidities and co-medications
The five most common comorbidities among the participant (n = 340) were hypertension (43.2%), diabetes (17.9%), chronic obstructive pulmonary disease (COPD) (5.6%), hyperlipidemia (5.6%), and dementia (4.7%) (see Supplementary Table 2 ). Increased number of people in the late-onset group had at least one comorbidity than the early-onset group (64.4% vs. 48.9%, p = 0.045). More of those in the late-onset group were diagnosed with hypertension than earlyonset group (45.8% vs. 26.7%, p = 0.016).
25.9% of the participants took at least one potential proconvulsant drug (see Supplementary Table 3 for more details). No significant difference in the administration of such drugs was found between two groups.
Risk factors for epilepsy prognosis
Logistic regression analysis indicated that late-onset epilepsies and AEDs treatment were associated with more favorable seizure outcome at two-year follow-up (see Table 3 ).
Discussion
Currently, little is known about the pattern of epilepsy in older people in China. We prospectively assessed the clinical features and seizure control of a large cohort of elderly people who were hospitalized due to epilepsy.
Seizure semiology
Focal seizure was the most commonly occurred seizure type while generalized seizure was rarely observed, which is in keeping with previous reposts [8, 9] . Some studies have, however, reported that 75% of older people with epilepsy had generalized seizures [10] while another study found no differences [11] . It is likely that the high occurrence of cerebral pathology in older people is responsible for the predominance of focal-onset epilepsy in our group.
Status epilepticus
SE is reported to occur in up to 12% of adults with epilepsy [14] . In our study, almost two thirds of participants had at least one episode of SE and it was more prevalent in the late-onset group. The higher prevalence of SE in our study may be due to different definitions between our and previous studies, where SE was used to be defined as more than 30 min of continuous seizure activity [10] . Besides, more than 60% of patients were found of underlying brain pathologies in our study, such as stroke and post-surgical changes, which may also lead to higher incidence of SE in older people when compared with younger patients.
Etiology of epilepsy
Structural epilepsy was prevalent in elderly epilepsies. Around two thirds of our cases had a structural pathologies likely to be associated with epilepsy. The proportion of those with brain structural abnormalities was even higher in the late-onset group as suggested before [8] . It was also previously reported that 70% of late-onset epilepsies and 40% of early-onset epilepsies were symptomatic [9] , which is similar to our findings. Therefore, physicians should carefully ascertain possible underlying etiologies when dealing with older people with epilepsy.
Genetic epilepsy is rarely seen in the elderly and this was the case in the study. However, no systematic genetic analyses were performed due to the high cost and inaccessibility of genetic testing. The practical application of the new classification was challenging and some potential diagnosable cases of genetic epilepsy may not be recognized.
Potential causes
Stroke was diagnosed as potential cause for 30% of all epileptic cases, which was the leading cause for epilepsies in our cohort. This is in accordance with finding in western countries [9, 15, 16] . Ischemic stroke (22.6%) was more common than hemorrhagic stroke (6.5%) as previously reported [17, 18] . Hippocampus sclerosis was rarely seen in our population and this is accordance with previous finding [9] .
AEDs applications
Approximately 80% of the participants were treated with longterm AEDs and 40% were on monotherapy. Sodium valproate was most frequently prescribed, as reported from western countries [19, 20] , but this differs from reports from Africa, South America, and Japan [15, 21, 22] . ILAE recommends lamotrigine and gabapentin for older people [23] but these drugs were not often used in our population.
Seizure control
Most of our study population responded well to AEDs treatment, which was even more evident in late-onset epilepsies and this is in accordance with previous studies [24] . Taking AEDs had a significant positive impact on the seizure outcome. However, the number of AEDs prescribed made no difference. Previous studies also demonstrated that with increasing age at seizure onset, elderly patients need less AEDs to attain satisfactory seizure control [25] . Considering the fact that elderly patients usually take Logistic regression models and optimum subsets regression were applied. drugs for comorbidities at the same time, it is reasonable to suggest monotherapy to avoid potential drug interactions and excessive side effect.
Comorbidities
Hypertension, diabetes, and COPD were most commonly seen in our study. The high prevalence of hypertension and diabetes would serve as a potential cause for stroke, which is also associated with epilepsy and SE according to the findings of previous studies [26, 27] . As suggested above, more strict surveillance and control of hypertension and diabetes may be reasonable in the elderly patients to reduce the incidence of stroke and associated complications, as well as epilepsy and SE. Further studies to explore whether strict intervention of hypertension and other comorbidities have positive effect on elderly epilepsy and SE might provide more evidence for clinical practice. Compared to studies conducted in other centers, tumors and myocardial infarction were less commonly diagnosed in our cohort, suggesting regional and ethnic differences [9] .
Co-medications
Older people with epilepsy use more co-medications than younger people [28] . In our cohort, around 25% of all patients took at least one medication that was potentially pro-convulsant. Although no negative impact on seizure prognosis was found by logistic regression, physicians should still be cautious when prescribing drugs with preconvulsant potential to older people with epilepsy.
Prognosis of epilepsy
Our results suggest that older people with late-onset epilepsies had an over fourfold chance of achieving satisfactory seizure controls compared to those with early-onset epilepsies. The use of AEDs increased the chances of better prognosis by 92-fold. Thus, AEDs treatment is strongly recommended after the diagnosis of epilepsy.
Limitations
Our study has several limitations. Firstly, only patients that were admitted to inpatient department were included. Most of them were hospitalized as they might have a more severe condition and this may have introduced a bias. Secondly, few patients in early-onset group had experienced several seizure attacks before age of 65, but for some unknown reasons such as ignorance of symptoms, failure of seeking for medical help due to lack of medical knowledge, or misrecognize of the disease by local doctors, leading to no diagnosis or treatment before. These patients might share similarities with uncontrolled adult epilepsies. Still, they were newly diagnosed and never been treated before. The generalization of this study may be limited, but it provided some evidence for those who were first diagnosed of epilepsy and treated in their elderly life. Thirdly, the application rate of EEG for epilepsy diagnosis was merely around 50%, which was not significantly improved during last few year in our hospital [12] . It might decrease the accuracy of diagnosis especially on seizure semiology. As other studies also showed a decline in the use of EEG in people aged 65 and above [13] , EEG monitoring for the elderly is usually not recommended as a standard diagnosis procedure and the diagnosis is made on clinical grounds. In our study, patients were only followed up for two years, thus the long-term effectiveness of AEDs is unknown.
Conclusions
Most epilepsy in our population was focal-onset, usually as a consequence of a cerebrovascular disease. SE was more commonly seen in the elderly patients than in adults. The overall effectiveness of AEDs treatment in elderly patients was satisfactory. Late-onset and AEDs treatment were associated with better outcome. When dealing with elderly epilepsies, the unique characteristics should be tackled with care.
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